For all the latest events, product news, research and development updates from Ectron and partners
WELCOME TO ECTRON
Ectron was founded in 1950 by the late Dr. Russell to manufacture medical equipment for the use within psychiatry and went on to become the world’s leading manufacturer of Electro Convulsive Therapy (ECT) devices. Ectron has since expanded its range of products and is now working with international partners in new exciting areas including MagVita TMS therapy for the treatment of Major Depressive Disorder (MDD). Ectron is renowned for providing the highest quality, medical device technology to researchers, clinicians, physiotherapists and patients.
Ectron's key business is to supply the latest medical devices for use in neurology, psychology, psychiatry and neurological rehabilitation. The company prides itself on introducing new and emerging technologies along with supplying established products, focusing on research, diagnostics, treatment and rehabilitation of neurological disorders.
WHY CHOOSE ECTRON?
Knowledge leaders for upper limb rehabilatation devices, rTMS, MagPro
Leading provider of ECT devices rTMS and Upper Limb Rehabilitation
rTMS NICE approved
Only UK distributor for Magventure, Tyromotion and ECT
Ectron recently spent time at SmartTMS and spoke to Dr. Leigh A Neal MD FRCPsych, the Medical Director of SmartTMS, about his experience of MagVita TMS Therapy for the treatment of Depression.
Dr. Neal has been a Consultant Psychiatrist for over 20 years and has worked in the Armed Forces, the NHS and the Independent Sector. He has been trained and certified in the safe use of MagVita TMS therapy systems by Maastricht University and uses MagVita TMS Therapy System at SmartTMS in London with great success.
For more information about MagVita TMS therapy systems for your hospital or clinic, please visit our websitewww.ectron.co.ukor call 0117 941 3979 or email: email@example.com For more information about Smart TMS please visit their website: www.smartTMS.co.uk
or call 0800 088 6060
In December 2015, the National Institute for Health and Care Excellence (NICE) approved rTMS (Repetitive Transcranial Magnetic Stimulation) as an effective and safe method of treating depression for patients in the UK. Repetitive Transcranial Magnetic Stimulation (rTMS) is a treatment which uses pulsing magnetic fields to activate brain centres associated with mood. The treatment has a number of advantages over traditional medication as it is non-invasive. It does not involve surgery, anesthesia or sedation and it does not have the side effects associated with antidepressants. rTMS has also been shown effective in treating migraine, post-natal depression and pain.
The guidelines issued by NICE have not specified or restricted the type of rTMS treatment, which means that practitioners can offer treatment using conventional rTMS – which takes around 40 minutes per session – and/or theta burst,
which takes around 5 minutes.
Ectron are the UK exclusive distributors of Magventure's rTMS system known as Magvita. This is the only system that has been awarded a CE mark for clinical use.
For more information about TMS for your hospital or clinic please email firstname.lastname@example.org
TMS is now available at a growing number of both private and NHS clinics across the UK. To find your nearest clinic please follow the link: TMS Clinics